ArchiveFebruary 2016

How to report epidemiology studies

Fiest KM, Marrie RA, Jette N, Bennett DA. The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis. Mult Scler. 2016 Feb 26. pii: 1352458516634873. [Epub ahead of print] BACKGROUND:Descriptive epidemiological studies documenting the incidence and prevalence of multiple sclerosis (MS) and studies that report morbidity, mortality, and economic...

Tolerability of Di Methyl Fumarate

Fox EJ, Vasquez A, Grainger W, Ma TS, von Hehn C, Walsh J, Li J, Zambrano J.Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).Int J MS Care. 2016 Jan-Feb;18(1):9-18. doi: 10.7224/1537-2073.2014-101 BACKGROUND: In phase 3 trials, delayed-release dimethyl fumarate (DMF; also...

Extending the Dose interval of natalizumab

Extended interval dosing of natalizumab in multiple sclerosis.Zhovtis Ryerson L, Frohman TC, Foley J, Kister I, Weinstock-Guttman B, Tornatore C, Pandey K, Donnelly S, Pawate S, Bomprezzi R, Smith D, Kolb C, Qureshi S, Okuda D, Kalina J, Rimler Z, Green R, Monson N, Hoyt T, Bradshaw M, Fallon J, Chamot E, Bucello M, Beh S, Cutter G, Major E, Herbert J, Frohman EM.J Neurol Neurosurg Psychiatry...

MS is Asia

Eskandarieh S, Heydarpour P, Minagar A, Pourmand S, Sahraian MA.Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review. Neuroepidemiology. 2016 ;46(3):209-221.  BACKGROUND: Multiple sclerosis (MS) is one of the most common chronic immune-mediated diseases of the human central nervous system and an important cause of non-traumatic neurologic...

Imaging myelination

Dynamic imaging of individual remyelination profiles in multiple sclerosis.Bodini B, Veronese M, García-Lorenzo D, Battaglini M, Poirion E, Chardain A, Freeman L, Louapre C, Tchikviladze M, Papeix C, Dollé F, Zalc B, Lubetzki C, Bottlaender M, Turkheimer F, Stankoff B. Anals Neurol. 2016. doi: 10.1002/ana.24620. [Epub ahead of print] BACKGROUND: Quantitative in vivo imaging of myelin...

Collecting Stem Cells

Kyrcz-Krzemień S, Helbig G, Torba K, Koclęga A, Krawczyk-Kuliś M. Safety and efficacy of haematopoietic stem cells mobilization in patients with multiple sclerosis. Hematology. 2016 Feb. [Epub ahead of print] Introduction Multiple sclerosis (MS) is a T-cell-mediated chronic inflammatory disorder of the central nervous system. Several agents have been approved for treatment of MS...

Cannabis Discontinuation

Fernández Ó.THC:CBD in Daily Practice: Available Data from UK, Germany and Spain Eur Neurol. 2016;75 Suppl 1:1-3. BACKGROUND:From the time Sativex (THC:CBD) oromucosal spray first became available in European Union countries in 2010 for the management of treatment-resistant multiple sclerosis (MS) spasticity, data from daily practice have been collected through various projects.METHODS:A...

Waning Interest in CCSVI

Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational Study.Metz LM, Greenfield J, Marrie RA, Jette N, Blevins G, Svenson LW, Alikhani K, Wall W, Dhaliwal R, Suchowersky O. Can J Neurol Sci. 2016 Feb 4:1-8. [Epub ahead of print] BACKGROUND:Many Canadians with multiple sclerosis (MS) have recently travelled internationally to have procedures for a putative...

Translate

Categories

Recent Posts

Recent Comments

Archives